PepDiana
Back to Evidence
Primary experimental recordNegative / threshold

PMC13231543::ACT047727

sP10

Evidence text

Paper-level observation

while showing no significant effects on AML12 normal hepatocytes (Fig. 4F).
figureConfidence: medium

Assay observation

Activity
Toxicity
Subtype
Cytotoxic
Measure
qualitative
Comparator
=
Raw observation
no significant effect
Normalized measurement
Not reported by source
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
AML-12
Assay method
Not reported by source
Sequence
YGRKKRRQRRRCGPVWFLIFSYFLFFSISLARGPC
Standardization
ready simple

Source publication

Peptide aptamer sP10 targeting NPM1 attenuates liver fibrosis and hepatocellular carcinoma.

Journal of Translational Medicine · 2026

DOI 10.1186/s12967-026-08144-8 PMC13231543
Parent mention

Related peptide identities

PEPDIA-PLP-003251

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.